Latest Breaking News On - Generex biotechnology corp - Page 4 : comparemela.com

Drug Delivery Technology Market 2021 by Global Industry Revenue, Current Trend, Size, Share, Competition, Growth, Price| La Roche AG, Merck Sharp & Dohme Corp, Bayer AG, Pfizer, Novartis AG, 3M – KSU

Drug Delivery Technology Market 2021 by Global Industry Revenue, Current Trend, Size, Share, Competition, Growth, Price| La Roche AG, Merck Sharp & Dohme Corp, Bayer AG, Pfizer, Novartis AG, 3M – KSU
ksusentinel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ksusentinel.com Daily Mail and Mail on Sunday newspapers.

United statesHong kongUnited kingdomNew zealandSouth koreaSouth africaUnited arab emiratesSaudi arabiaGene banksSmartdose genAsia pacificDrug delivery technology market developmentDrug delivery technology market scenarioTheir company profileGlobal macroeconomic environment development trendsGenerex biotechnology corp

Insider Moves: Bintai Kinden Corp Bhd, Jiankun International Bhd, PNE PCB Bhd, Scope Industries Bhd, Kenanga Investment Bank Bhd, Sunzen Biotech Bhd

Notable filings BETWEEN Jan 11 and 15, notable shareholding changes took place at several companies listed on Bursa Malaysia, including Bintai Kinden Corp Bhd, a mechanical and electrical engineering firm that is venturing into the healthcare sector by distributing a Covid-19 vaccine in Southeast Asia. In a Jan 11 filing, loss-making Bintai Kinden said Handal Jayabina Sdn Bhd had ceased to be a substantial shareholder after divesting 15 million shares or a 3.93% stake on the open market on Jan 7. It is worth noting that Melaka-based Handal Jayabina had just emerged as a substantial shareholder on Jan 6. As part settlement of outstanding debts owed by Optimal Property Management Sdn Bhd, a wholly-owned subsidiary of Bintai Kinden, 31.8 million shares representing a direct stake of 8.32% were issued to Handal Jayabina. Following the divestment on Jan 7, it is estimated that it still holds about 4.39% of Bintai Kinden.

Negeri sembilanHandal jayabina sdn bhdYee wei mengNugenerex immunoBintai kindenSdn bhdCita realiti sdn bhdHandal jayabinaDatuk hong choon hauChuanplus industries sdn bhdKenanga investment bank bhdMalaysia pacific corp bhdUbs agBintai kinden corp bhdScope industries bhdGoodway integrated industries bhd

Bintai Kinden diversifies into property business, less than six months after vaccine venture

KUALA LUMPUR (Jan 21): Bintai Kinden Corp Bhd, whose share price has more than halved since it hit its record high of RM1.39 in early December, announced that it intends to diversify into property development and management as a strategy to reduce its “reliance solely on the mechanical and electrical (M&E) engineering business”. On top of that, the company is also proposing a private placement exercise to raise fresh capital of RM58.43 million to fund the new venture. It is worth noting that this is the second venture out of its core M&E business in less than six months.

Kuala lumpurMelaka tengahEast timorRepublic ofSdn bhdHolistica melakaNugenerex immunoBintai kindenGenerex biotechnology corpNusankota development sdn bhdOncology incBintai holdingsm sdn bhdBintai kinden corp bhdBintai healthcare sdn bhdNugenerex immuno oncology incGreenie medi cold chain box

Still some ways to go for Malaysian companies vaccine distribution biz to take off

KUALA LUMPUR (Jan 12): Promising developments on the vaccine front have stirred investor interest in companies that venture into vaccine distribution, in hopes they will be in for bumper profits. However, it is not clear at this juncture just how much or when these companies can cash in, given just the evaluation process alone for a vaccine to be approved for distribution and use in Malaysia will take five phases. The first phase alone which is the checking of the vaccine dossiers or research documents typically takes between 90 and 120 days, according to the Ministry of Health (MoH). When contacted, property developer Yong Tai Bhd chief executive officer Datuk Wira Boo Kuang Loon said the company expects to bring its Chinese partner s vaccine into Malaysia by the third quarter of this year, at the earliest, on obtaining approval from the MoH s National Pharmaceutical Regulatory Agency (NPRA). Any vaccines or medicines to be imported into Malaysia for use here will require NPRA

Kuala lumpurYong taiNew zealandChoon luiBintai kindenNugenerex immunoYong tai bhdKinsel sdn bhdGenting bhdSolution group bhdNusankota development sdn bhdBintai kinden corp bhdGenerex biotechnology corpSports ltdMy eg services bhdKanger international bhd

Penny Stock: A once-in-two-decade penny stock fever

IF 2020 is the year of rubber glove manufacturers and technology-related counters, penny stocks deserve at least a notable mention. The penny stock fever on the local bourse has not been seen for at least 20 years since the dotcom bubble burst. The eye-popping share price rally lured long-absent retail investors to the stock market and that, in turn, lifted the daily trading volume to a record high of 27.8 billion shares on Aug 11. At the height of the penny stock fever in August, share prices hitting limit up were not a rare sight. On Aug 7, 12 stocks hit limit up, including HLT Global Bhd, LKL International Bhd and ES Ceramics Technology Bhd. These three were below 20 at the start of 2020.

Bintai kindenNugenerex immunoJason chia kok chinSdn bhdChia kok teongBok tekYong tai bhdKonsortium transnasional bhdKomarkcorp bhdGenting bhdNusankota development sdn bhdEs ceramics technology bhdGenerex biotechnology corpSaudee group bhdMy eg services bhdOncology inc